Last updated 15 days ago

A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) Metastases

220 patients around the world
Available in Mexico, Brazil, Spain
Hoffmann-La Roche
9Research sites
220Patients around the world
This study is for people with
Lung cancer
Non-small cell lung carcinoma
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Ynova Pesquisa Clinica
Recruiting
Rua Menino Deus, 63 / Bloco A - Sala 303 Centro - Florianópolis - SC
Hospital Sao Rafael
Recruiting
Av. São Rafael, 2152 - São Marcos, Salvador - BA, 41253-190
Oncocentro Serviços Médicos e Hospitalares Ltda
Recruiting
Av. Pontes Vieira, 2571 - Dionísio Torres, Fortaleza - CE, 60135-237
Oncocentro - Belo Horizonte
Recruiting
R. Roma, 561 - 4 andar - Santa Lúcia, Belo Horizonte - MG, 30360-680
ONCOSITE - Centro de Pesquisa Clinica em Oncologia
Recruiting
Ijui, 98700-000
Universidad Autónoma de Nuevo León, Hospital Universitario Dr. José Eleuterio González
Universidad Autónoma de Nuevo León, Hospital Universitario Dr. José Eleuterio González
Recruiting
Av. Madero y Gonzalitos S/N, Mitras Centro, Monterrey, Nuevo León
Health Pharma Professional Research
Recruiting
Dakota 351, Nápoles, Benito Juárez, 03840 Ciudad de México, CDMX, Mexico
Superare - Centro de Infusión
Recruiting
Ciudad de México, Mexico CITY (federal District), 06760
Hospital Civil de Guadalajara Fray Antonio Alcalde
Recruiting
Guadalajara, Jalisco, Mexico, 44280
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy